When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Granuloma annulare

Last reviewed: 8 Aug 2025
Last updated: 26 Nov 2020

Summary

Definition

History and exam

Key diagnostic factors

  • asymptomatic grouped annular pink or flesh-colored dermal papules
Todos los datos

Otros factores de diagnóstico

  • flesh-colored, pink, or brown macules or small papules
  • soft-tissue nodules
  • perforating papules, crusting or ulcerated lesions
  • erythematous patches
Todos los datos

Factores de riesgo

  • diabetes mellitus
  • hematologic malignancy
  • herpes zoster
  • HIV
  • hepatitis
  • hyperlipidemia
  • thyroid disease
  • medications
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • clinical diagnosis
Todos los datos

Pruebas diagnósticas que deben considerarse

  • skin biopsy
  • fasting blood sugar
  • thyroid function tests
  • lipid screening
  • hepatitis screen
  • HIV testing
Todos los datos

Algoritmo de tratamiento

Agudo

localized variant (classic annular rash)

generalized variant (widespread macular rash)

perforating variant (crusted or ulcerated lesion)

subcutaneous variant (soft nodule)

patch variant (erythematous plaques)

Colaboradores

Autores

Misha Rosenbach, MD

Associate Professor

Dermatology and Internal Medicine

University of Pennsylvania

Philadelphia

PA

Divulgaciones

MR has received consulting fees from Merck, aTyr Pharma, and Processa Pharma, not related to granuloma annulare. He has received grant support from Processa Pharma, not related to granuloma annulare. MR has received salary support from the AMA/JAMA for his role at JAMA Dermatology as Deputy Editor. MR is an author of references cited in this topic.

Agradecimientos

Dr Misha Rosenbach would like to gratefully acknowledge Dr Susmita Mukherjee, a previous contributor to this topic. SM declares that she has no competing interests.

Revisores por pares

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

Divulgaciones

AS declares that she has no competing interests.

Robert Herd, MSc, MD, FRCP

Consultant Dermatologist

Department of Dermatology

Nuffield Hospital

Glasgow

UK

Divulgaciones

RH declares that he has no competing interests.

Brenda L. Pellicane, MD

Dermatologist

Wayne State University School of Medicine

Department of Dermatology

Detroit

MI

Divulgaciones

BLP declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Piette EW, Rosenbach M. Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol. 2016 Sep;75(3):457-65. Resumen

Thornsberry LA, English JC 3rd. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013 Aug;14(4):279-90. Resumen

Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016 Sep;75(3):467-79. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad